1DeRubeis, RJ, Zajecka, J, Shelton, RC, Amsterdam, JD, Fawcett, J, Xu, C, et al. Prevention of recurrence after recovery from a major depressive episode with antidepressant medication alone or in combination with cognitive behavioral therapy. A phase 2 randomized clinical trial. JAMA Psychiatry 4 Dec 2019 (doi:10.1001/jamapsychiatry.2019.3900).
2Dragioti, E, Solmi, M, Favaro, A, et al. Association of antidepressant use with adverse health outcomes a systematic umbrella review. JAMA Psychiatry 2019; 76: 1241–55.
3Davis, KA, Farooq, S, Hayes, J, John, A, Lee, W, MacCabe, JH, et al. Pharmacoepidemiology research: delivering evidence about drug safety and effectiveness in mental health. Lancet Psychiatry 25 Nov 2019 (https://doi.org/10.1016/S2215-0366(19)30298-6). 4Kennis, M, Gerritsen, L, van Dalen, M, Willaims, A, Cuijpers, P, Bocktling, , et al. Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis. Mol Psychiatry 19 Nov 2019 (https://doi.org/10.1038/s41380-019-0585-z).
5Das, RK, Gale, G, Walsh, K, Hennessy, VE, Iskandar, G, Mordecai, LA, et al. Ketamine can reduce harmful drinking by pharmacologically rewriting drinking memories. Nat Commun 2019; 10: 5187.
6Lerchenmuller, MJ, Sorenson, O, Jena, AB. Gender differences in how scientists present the importance of their research: observational study. BMJ 2019; 367: I6573.
7Silbiger, NJ, Stubler, AD. Unprofessional peer reviews disproportionately harm underrepresented groups in STEM. Peer J 2019; 7: e8247.